Parkwalk Advisors is a venture capital firm that focuses on investing in high-growth, knowledge-intensive university spinouts with strong intellectual property, originating from leading UK academic institutions. Their strategy involves backing companies across deeptech sectors like AI, quantum computing, cleantech, digital health, and life sciences, bridging the gap between early academic discovery and later-stage venture capital.
Portfolio
12
Fund Size
$665M
Top Stage
Seed
Last 12 Mo
5
Stage Distribution
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Brainomix | Series C | $25.4M | Feb 2026 |
| xWatts | Seed | $1.6M | Feb 2026 |
| CamGene Therapeutics | Seed | — | Nov 2025 |
| Bitfount | Series A | $6.8M | Jul 2025 |
| Brainomix | Series C | $18M | Mar 2025 |
| Cambridge GaN Devices | Series C | $30.5M | Feb 2025 |
| OW Smell Made Digital | Seed | $2.8M | Aug 2024 |
| Psyomics | Series A | $5.1M | Jun 2024 |
| Phasecraft | Series A | $15M | Aug 2023 |
| Legislate | Seed | $3.6M | Mar 2023 |
| Echopoint Medical Ltd | Seed | $3.5M | Sep 2019 |
| Undo | Series B | $14M | Jul 2018 |
Top Co-Investors
AlbionVC2 shared
UCL Technology Fund2 shared
Cambridge Innovation Capital2 shared
Foresight Ventures2 shared
Cambridge Enterprise2 shared
Boehringer Ingelheim Venture Fund1 shared
LifeSci Venture Partners1 shared
Hostplus1 shared
British Patient Capital1 shared
BGF1 shared
IQ Capital1 shared
Playground Global1 shared
London Co-Investment Fund (LCIF)1 shared
UKi2S1 shared
Global Brain Corporation1 shared
Ahren Innovation Capital1 shared
Portfolio Ventures1 shared
Oxford Capital1 shared
Last updated: 3 March 2026